A comparable limitation applies to many studies focusing on BRCA1/2 mutation carriers alone, in particular those dealing with single selected issues like, for example, the effect of salpingo-oophorectomy on BC risk [42], the psychosocial well-being after risk-reducing surgery [43], and the results of magnetic resonance imaging and mammography screening [44]. The gene discussed is BRCA1; the disease is breast cancer.